Literature summary for 5.3.99.5 extracted from

Yoshida, T.; Kameda, H.; Masashi, A.; Homma, M.; Ikeda, Y.
Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in Lupus nephritis (1997), Adv. Exp. Med. Biol., 433, 113-117.

Search for more literature for 5.3.99.5

Application

Application	Comment	Organism
medicine	improvement of the renal function with the selective thromboxane A2 synthetase inhibitor (+/-)-6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrochloride hemihydrate	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
(+/-)-6-(1-Imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrochloride hemihydrate	improvement of the renal function with the selective thromboxane A2 synthetase inhibitor	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
Prostaglandin H2	i.e. PGH2	Homo sapiens	thromboxane B2 + 12(L)-hydroxy-5,8,10-heptadecatrienoic acid	-	?

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)